

Fatal Experiments: The Downfall of a Supersurgeon
The series investigates Paolo Macchiarini’s claims to have invented a ground-breaking method to create new organs. His method using plastic tracheas sown with stemcells has been operated on patients in the US, Russia, Sweden and the UK. So far, unfortunately, the track record of his plastic organs is not very good. Almost all patients are dead. And several of his former surgeon colleagues in Sweden claim that not only does the method not work, but that his scientific claim to fame is based on falsified and misrepresented data. Some even claim that his patients have been used as human guinea-pigs.
Sign in to add to your listWhat critics are saying
Verdicts use the same scale as your list: highly recommended through avoid — plus optional scores and blurbs.
Nobody on Critic, Sir! has logged a verdict for this title yet. The silence is either respectful or suspicious.
Sign in and use Add to My List below to share your own verdict.
Cast
Seasons

1.Part 1
10.013-01-201658mPaolo Macchiarini is one of world's most famous surgeons. He hopes to revolutionize medicine by creating a new type of synthetic organ - a vision that could save many lives. But th...

2.Part 2
10.020-01-201658mIn the summer of 2012, supersurgeon Macchiarini is under pressure when problems start to arise. His pioneering transplant work seems at risk when he discovers faults with the new s...

3.Part 3
10.027-01-201659mBy 2014, four Karolinska doctors started to question Macchiarini's transplantation of plastic tracheas and raised the alarm at Karolinska University Hospital and Karolinska Institu...
Watching Lists
Sign in to create and edit public lists.
Loading lists…
Purchase & Discovery
Find this title on Amazon
Digital
Prime Video & digitalAmazon mixes rent, buy, and Prime in one place — one search covers the usual options.
Physical edition
4K Blu-ray & physical releasesSearch on AmazonOfficial merchandise
Official-style merch searchApparel, collectibles, and moreAs an Amazon Associate, Critic, Sir! earns from qualifying purchases. Full disclosure



